Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluad versus Agriflu and Fluzone in children 6 to <72 months
2014-005053-40Phase 3
- Sponsor
- Novartis
- Start
- Nov 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Fluzone Trivalent and influenza vaccine in influenza (3 arms), sponsored by Novartis. Primary endpoints: Comparison of antibody responses of aTIV with TIV and comparator TIV in terms of geometric mean titers against homologous strains, Noninferiority of Fluad versus Agriflu and Fluzone by seroconversion and 1 more.
02
Drugs
Fluzone Trivalentinfluenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2014-005053-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005053-40.